Browse by field and institution
Biotechnology & Life Sciences at University of California
Genetics, cell biology, biochemistry, microbiology and pharmaceutical preparations. The 65 Biotechnology & Life Sciences technologies University of California markets for licensing, each joined to the patent record diligence turns on: who owns it now, whether it is still in force, and how many years of exclusive term remain.
| Published | Technology | Status | Owner | Expiry |
|---|---|---|---|---|
| 2025-08-19 | Fusion constructs as protein over-expression vectors University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-06-23). |
| 2025-03-11 | Method for genetic manipulation of sap-feeding insects University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 15.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-04-12). |
| 2024-12-10 | Chimeric antigen receptor and methods of use thereof University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-04-13). |
| 2024-08-13 | Compositions and methods for delivery of macromolecules University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 14.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-02-05). |
| 2024-08-06 | Method for diagnosing risk for inflammatory disease through glycan profiling University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 14.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-01-27). |
| 2024-05-07 | Fusion proteins and methods for site-directed genome editing University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-11-20). |
| 2024-01-30 | Hepatic inflammation analysis with dynamic PET University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 14.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-01-22). |
| 2023-09-19 | Method and molecules University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is MedImmune LLC, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 13.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-08-03). |
| 2023-07-11 | Prodrug for therapeutic applications University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 15.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2041-05-27). |
| 2023-07-04 | Fast diagnosis and personalized treatments for acne University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 6.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-03-15). |
| 2023-01-03 | Noncrushable pill formulations University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-06-09). |
| 2022-12-06 | High-efficiency particle encapsulation in droplets with particle spacing and downstream droplet sorting University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 13.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-10-30). |
| 2022-09-20 | Generation of haploid plants University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-12-23). |
| 2022-04-05 | Heterocyclyl polymethine IR chromophores University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-06-05). |
| 2022-03-01 | Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Altor Bioscience LLC, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 2.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2028-10-27). |
| 2022-02-22 | Immunoassay for human erythroferrone University of California | Expired - Fee RelatedExpired early due to an unpaid maintenance fee (US patents owe fees at 3.5, 7.5 and 11.5 years), not by reaching the end of its term. Such lapses can sometimes be revived. | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-05-28). |
| 2022-02-22 | CRISPR/Cas transcriptional modulation University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-07-14). |
| 2021-11-16 | Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-03-23). |
| 2021-10-05 | Conditionally active heterodimeric polypeptides and methods of use thereof University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-01-06). |
| 2021-09-28 | Systems, apparatus and methods for cryogenic 3D printing University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 12.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-06-28). |
| 2021-06-29 | Method for finding low abundance sequences by hybridization (FLASH) University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 11.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-03-22). |
| 2021-06-22 | Methods for detection of RNase activity University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-03-16). |
| 2021-02-16 | Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation University of California | Active - ReinstatedIn force, but previously lapsed and reinstated -- confirm its current standing and fee history. | Third partyThe patent's current assignee of record is Marine Biological Laboratory, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 8.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-11-21). |
| 2021-02-09 | Tubulin-binding compounds, compositions and uses related thereto University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-05-26). |
| 2020-12-15 | Bioactive delivery vehicles University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-06-24). |
| 2020-09-08 | Methods and compositions to increase the rate of ligation reactions catalyzed by a sortase University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-02-20). |
| 2020-08-11 | Negative regulator of plant immunity against nematodes University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 11.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-03-05). |
| 2020-03-10 | Immunoproteasome inhibitor analogs University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Michigan State University MSU, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 10.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-03-10). |
| 2019-12-31 | Compositions and methods related to hematologic recovery University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-11-24). |
| 2019-12-10 | Multiple-use renewable electrochemical sensors based on direct drawing of enzymatic inks University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-04-14). |
| 2019-10-22 | Sorafenib derivatives as p21 inhibitors University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-06-20). |
| 2019-10-01 | Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-09-29). |
| 2019-08-06 | Technology for sustaining pluripotency and improved growth of stem cells in culture University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 10.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-12-29). |
| 2019-07-23 | Biological platform for production of commodity chemicals University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 8.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-04-28). |
| 2019-07-16 | Acene-based transmitter molecules for photon upconversion University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 11.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-02-16). |
| 2019-03-12 | Glycosphingolipids for use in modulating immune responses University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Harvard University, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 7.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-11-04). |
| 2019-02-26 | Plant growth-promoting microorganisms and methods of use thereof University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is BG Negev Technologies and Applications Ltd, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 8.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-06-10). |
| 2019-02-12 | Codon-optimized lentiviral vector for stem cell reprogramming University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-01-28). |
| 2019-01-29 | MPS peptides and use thereof University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 8.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-07-25). |
| 2019-01-08 | Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 8.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-10-15). |
| 2018-10-30 | Compounds and methods for modulating vascular injury University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Brigham and Womens Hospital Inc, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 7.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-09-09). |
| 2018-09-25 | Method and system for ultra-high dynamic range nucleic acid quantification University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 9.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-05-16). |
| 2018-06-19 | Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 8.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-07-16). |
| 2018-05-29 | Membrane template synthesis of microtube engines University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 6.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-06-04). |
| 2018-03-06 | Non-thermal cycling for polymerase chain reaction University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-07-13). |
| 2018-01-30 | Bioactive agent delivery devices and methods of making and using the same University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-12-03). |
| 2017-10-31 | Prevention of rosacea inflammation University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-12). |
| 2017-10-17 | Methods and systems for determining a likelihood of adverse prostate cancer pathology University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-11-01). |
| 2017-06-27 | Polymeric nanocarriers with linear dual response mechanism University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 5.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-04-21). |
| 2017-04-18 | Decellularized extracellular matrix University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-10-02). |
| 2017-02-21 | Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 3.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-09-28). |
| 2017-01-31 | Compositions and methods for quadricyclane modification of biomolecules University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-05-03). |
| 2016-11-15 | Cardiosphere derived cell population and methods of use University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-11-05). |
| 2016-11-01 | Fermented wheat germ proteins (FWGP) for the treatment of cancer University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 4.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2030-11-02). |
| 2016-08-30 | Methods of producing acetoin and 2,3-butanediol using photosynthetic microorganisms University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 7.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-09-27). |
| 2016-05-10 | Polypeptides for use in the deconstruction of cellulose University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is University of Maryland Baltimore, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 5.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-11-20). |
| 2016-04-05 | Method and compositions comprising small RNA agonist and antagonists to modulate inflammation University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Assigned awayThe patent's current assignee of record is Office of General Counsel of VA, not University of California; it appears to have been assigned away. Confirm licensing rights with the current owner. | Active termAbout 5.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-04-05). |
| 2015-12-08 | Use of IL-17D for the treatment and prevention of cancers University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 5.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-04-05). |
| 2015-10-13 | Glycopeptides and methods of making and using them University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 5.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-06-20). |
| 2015-07-07 | Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Kamanna Shobha V, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 5.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2031-11-22). |
| 2015-07-07 | Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Rhode Island Board of Education, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 5.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-03-26). |
| 2015-06-02 | Systems and methods for selectively migrating cells using electric fields University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 6.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-03-15). |
| 2015-05-26 | Nanofibers and morphology shifting micelles University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | Active termAbout 4.2 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2030-08-03). |
| 2014-01-07 | Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions University of California | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is University of Connecticut, not University of California. Confirm licensing rights with the assignee of record. | Active termAbout 6.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2032-11-09). |
| 2004-11-02 | Nucleic acid detection methods using universal priming University of California | Expired - LifetimeExpired by reaching the end of its statutory term, not by an unpaid fee. The invention is now in the public domain -- free to practise, with no exclusive patent right left to license. | InstitutionThe patent's current assignee of record matches the marketing institution (University of California). | ExpiredThe expected expiration date (2021-03-25) has passed, so little or no exclusive patent term is likely to remain. |
The Owner column flags when a patent's current assignee of record is not the marketing institution (a "Third party" or "Assigned away" tag means you may not be able to license it from that university). The Expiry column reads how much exclusive patent term remains: an "Expiring soon" or "Expired" tag means little or no exclusivity is left, whatever the listing says. Hover any tag for detail; click any column header to sort.